Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.375
Full Text
Open PDFAbstract
Available in full text
Date
November 24, 2008
Authors
Publisher
Springer Science and Business Media LLC